For the past ten years, I have looked forward with great enthusiasm to December because it marks my annual visit to London for the Digital Pathology Congress. This year, I have the opportunity to present our latest program.
A 13-year-old spayed female domestic shorthair cat was presented to a veterinary clinic with a history of a large mass, approximately 8 - 10 cm in size, with an irregular texture. The mass was located on the left caudal border of the scapula and exhibited firm attachment, extending approximately 2 cm across the spine. A fine-needle aspiration (FNA) was performed, and the sample was submitted to NationWide Laboratories for evaluation.
Diagnexia announces the launch of its enterprise-grade digital pathology platform that seamlessly connects US laboratories to its broad network of board-certified sub-specialty pathologists.
Welcome to PathPulse: Pathology Innovators in Action. Today, we’re honored to host Dr. Liron Pantanowitz, the Maud L. Menten Professor and Chair of the Department of Pathology at UPMC and the University of Pittsburgh. With a distinguished career spanning over two decades, Dr. Pantanowitz is a pioneer in digital and computational pathology.
In this whitepaper, PathAI provides an overview of how it has partnered with several institutions and laboratories around the world to build a business case for going digital.
HistoWiz, a leading provider of histopathology services, is excited to announce the integration of advanced AI tools from Aiosyn and AIRA Matrix into its PathologyMap™ platform.
Aiosyn, a pioneering innovator in AI-powered pathology software for cancer and kidney disease, is thrilled to announce the integration of its NephroPath AI tools into HistoWiz’s PathologyMap™ platform. This collaboration provides researchers using PathologyMap™ with state-of-the-art solutions for kidney tissue analysis, facilitating and accelerating scientific research.
Lumea partners with Mindpeak to integrate AI tools like Breast Suite and Gleason grading into its platform, advancing precision in digital pathology.
Modella AI, a pioneer in generative and agentic artificial intelligence for biomedicine, is proud to announce that its cutting-edge generative AI co-pilot, PathChat DX, has been granted Breakthrough Device Designation by the U.S.
Deciphex, the research pathology division of Deciphex, proudly announces the launch of Diagnexia Analytix, a comprehensive pathology service offering that integrates advanced analytics and AI-powered workflows with expert-led diagnostics to elevate study outcomes.
